普罗布考对颈动脉粥样硬化的影响60例临床研究附视频

被引：2

作者：

吴乐 ^{[1
]}

黎红华 ^{[1
]}

武强 ^{[1
]}

王晓昆 ^{[2
]}

机构：

[1] 广州军区武汉总医院神经内科

[2] 广州军区武汉总医院医学实验中心

来源：

神经损伤与功能重建 | 2010年 / 05期

关键词：

普罗布考; 颈动脉粥样硬化; 氧化低密度脂蛋白;

D O I：

暂无

中图分类号：

R543.4 [颈动、静脉疾病];

学科分类号：

摘要：

目的:观察普罗布考对颈动脉粥样硬化的作用。方法:颈动脉粥样硬化患者60例,随机分普罗布考组和对照组,各30例,普罗布考组患者接受普罗布考治疗(口服0.25 g/次,2次/d)3个月,对照组患者不接受降脂或抗氧化治疗。分别于治疗前后经彩色多普勒技术测定颈动脉斑块厚度,检测血氧化低密度脂蛋白(ox-LDL)水平。结果:治疗后,普罗布考组患者颈动脉斑块厚度明显减小,血ox-LDL水平降低。结论:普罗布考可能通过降低血ox-LDL水平途径,减轻颈动脉粥样硬化程度。

引用

页码：352 / 354

页数：3

共 7 条

[1]

Endotheliμm and vascular protection: an update. Badimon L,,Martinez-Gonzalez J. Revista Espanola de Cardiologia . 2002

[2]

Probucol en-hances the expression of human hepatic scavenger re-ceptor class B typeⅠ,possibly through a species-specifi mechanism. Kenich I,Chiaki I,Kenichi T,et al. Arteriosclerosis Thrombosis and Vascular Biology . 2005

[3]

Accumulation of LDL in rat arteries is associated with activation of tumor necrosis factor-alpha expression. Niemann-Jonsson A,Dimayuga P,Jovinge S,et al. Arteriosclerosis . 2000

[4]

Linkbetweeninfectionand atheroeclenosis:whoare the cul-prits:viruses,bacteria,both,orneither. ShahPK. Circulation . 2001

[5]

Long-term treatment with probucol improves endothelial function in patients with coronary artery disease. Tagawa T,Urabe Y,Kimura Y,et al. Hypertension Research . 2004

[6]

A reliable marker of endothelial cell dysfunction: does it exist?. Blann A D,Taberner D A. British Journal of Haematology . 1995

[7]

Probucol and multivitamins in the prevention of restenosis after coronary angioplasty. Multivitamins and Probucol Study Group. Tardif JC,Cote G,Lesperance J,et al. New England Journal of Medicine, The . 1997

← 1 →